Disitamab Vedotin in Combination with Metronomic Chemotherapy in Advanced HER2-expressing Breast Cancer.
Clinical trial NCT06857747 · UNKNOWN
Trial details
- NCT number
- NCT06857747
- Sponsor
- QIAO LI
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-01
- Primary completion
- 2025-12-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.